A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J)

Study Overview
=================
Brief Summary
-----------------
The primary goal for this study is to examine the effectiveness of community-based multimodal intervention program for suicide prevention in relatively high suicide rate region compared to control region. The secondary goal for this study is to explore the effectiveness of community-based multimodal intervention program for suicide prevention in the highly populated regions. In addition, we examine the effectiveness of the prevention program in the all regions combined.

Detailed Description
-----------------
Suicide is a major public health problem and the number of suicide victims has exceeded 30,000 a year since 1998 in Japan. Suicide rate is almost 25/100,000, which are remarkably high numbers among advanced countries. To examine the effectiveness of community-based multimodal intervention program for suicide prevention, a trial by J-MISP (Japanese Multimodal Intervention Trials for Suicide Prevention). This research project is one of the strategic research projects funded by The Japanese Ministry of Health, Labor and Welfare.

Official Title
-----------------
A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J)

Conditions
-----------------
Suicide

Intervention / Treatment
-----------------
* Behavioral: Multimodal suicide prevention program
* Behavioral: Suicide prevention program as usual


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Areas which meet the following criteria are eligible for this study; An area with firm support from local government and other organizations to conduct this multimodal suicide prevention program An area capable to select intervention and control regions An area capable to follow the data collection procedure described in the protocol An area with comparable baseline data on suicide attempts rate in intervention and control region An area with comparable baseline data on demographics in intervention and control region Exclusion Criteria: None
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Multimodal community intervention<br>Multimodal suicide prevention program | Behavioral: Multimodal suicide prevention program<br>* A community intervention of multimodal suicide prevention program includes following components: Building support networks for suicide prevention and mental health promotion in public health system Primary prevention of suicide and suicide related behaviors Secondary prevention of suicide and suicide related behaviors Tertiary prevention; after care for suicide survivors Suicide prevention targeting for people with substance/alcohol- related disorders , schizophrenia and other mental health disorders Suicide prevention targeting for people with work-related problems<br>|
| Active Comparator: Community intervention as usual<br>Suicide prevention program as usual | Behavioral: Suicide prevention program as usual<br>* Usual suicide prevention program<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of suicide attempts (completed suicides and suicide attempts except mild case ) |  | 3.5years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of completed suicides |  | 3.5years | 
| Incidence of suicide attempts |  | 3.5 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Suicide, Prevention, Community